Research use only · EU-warehoused · COA on every batch · HPLC ≥99% · Shipment 2–5 days
Log in Register
Home/ Catalogue/ Encapsulated Compounds/ NMN Capsules
In stock
NMN Capsules

NMN Capsules

Lyophilised · ≥99% (HPLC) ·

Quantity Volume discounts auto-applied
Custom quantity
1

Supplied lyophilised. Reconstitution typically uses bacteriostatic water.

Independently third-party tested · COA on every batch · 48h EU dispatch
[01]

Overview

Nicotinamide mononucleotide (NMN) is a naturally occurring ribonucleotide and direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme central to cellular energy metabolism, redox signalling, and sirtuin-dependent DNA-repair pathways. CAS 1094-61-7; molecular formula C₁₁H₁₅N₂O₈P; molecular weight 334.22 g/mol. Supplied in encapsulated form at ≥99% purity by HPLC. For laboratory research use only; not for human or veterinary use.

Every cell runs on a coenzyme so fundamental it is hard to overstate, and NMN sits one chemical step away from making it. β-Nicotinamide mononucleotide is a direct biosynthetic precursor of NAD+, the redox cofactor that powers energy metabolism and fuels the sirtuin and PARP enzyme families. As a small molecule positioned at the entry point of NAD+ synthesis, NMN has become a central tool in research on cellular energetics and ageing biology.

An entry point to NAD+ biology. In the salvage pathway, NMN is converted to NAD+ by NMNAT enzymes, making it a logical lever for studying NAD+ availability — a strategy reviewed extensively as part of the broader effort to map and target NAD+ metabolism (Migaud et al., 2024; Rice et al., 2024). Recent work has also re-examined how NMN actually reaches cells and tissues, identifying nicotinamide transporters and an enterohepatic route that reshape long-held assumptions about its delivery (Chen et al., 2025; Yaku et al., 2025).

The molecule's mechanistic appeal lies in the enzymes it feeds: NAD+-dependent sirtuins and the energy-sensing NAMPT node that sets cellular NAD+ supply under metabolic stress (Zu et al., 2025).

What the research explores. Across cell-culture and animal systems, NMN has been investigated along several converging lines:

  • NAD+ metabolism & mitochondrial function — studied as an NAD+-boosting precursor influencing mitochondrial quality control and homeostasis in disease models (Zhou et al., 2025; Migaud et al., 2024).
  • Cellular senescence & ageing pathways — examined for SIRT1/SIRT3-linked effects on senescence, hepatic and skin-ageing endpoints in cell and animal systems (Saka et al., 2026; Sun et al., 2025).
  • Skeletal-muscle & metabolic models — explored for muscle mass, function and high-fat-diet myocardial endpoints, including systematic-review synthesis (Prokopidis et al., 2025; Wen et al., 2026).

The activity described here is drawn from in-vitro and animal studies; it characterises biological behaviour in experimental models and does not establish efficacy or safety in humans. Full citations are listed under the Scientific References tab.

Physicochemical profile. CAS No. 1094-61-7 · Molecular formula C11H15N2O8P · Molecular weight 334.22 g/mol · Appearance: White crystalline powder · Solubility: Soluble in water.

Specification & quality. Each bottle contains 60 HPMC (vegan) capsules, each providing 500mg of NMN at ≥99% (HPLC). Encapsulated — no reconstitution required. Every batch is independently third-party tested, and a Certificate of Analysis (COA) is available. Store at -20°C for long-term; cool and dry short-term, protect from moisture; shelf life 24 months from the manufacture date. EU warehoused.

This product is intended for laboratory research use only (RUO). It is not a drug, food, cosmetic, or dietary supplement, and is not for human or veterinary use, ingestion, or diagnostic application. Handling is restricted to qualified research professionals operating in an appropriately equipped laboratory.

Supplied for in-vitro laboratory research use only (RUO). Not a drug, food or supplement; not for human or veterinary use.

[04]

Quality & COA

Certificate of Analysis
Lot-specific COA with every order

Certificate of Analysis — lot-specific COA ships with every order and is available on request.

Each lot is tested by an independent third-party laboratory for identity (mass spectrometry) and purity (HPLC). The Certificate of Analysis for your specific batch ships with the order and is available on request — no house data, no exceptions.

HPLC purity
≥99% (HPLC)
Method
HPLC + MS
Endotoxin
Reported
[02]

Data Sheet

CAS number1094-61-7
Molecular formulaC11H15N2O8P
Molecular weight334.22
Purity≥99% (HPLC)
Physical formWhite crystalline powder
Quantity60 capsules
SolubilitySoluble in water
StorageStore at -20°C for long-term; cool and dry short-term, protect from moisture
ReconstitutionEncapsulated — no reconstitution required.
Shelf life24 months from manufacture date
Dose per capsule500mg
Capsule materialHPMC (Vegan)
OriginEU · Slovakia
ClassificationResearch use only
[03]

Scientific References

01 Gallagher C, Emmanuel OO NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing research reviews. 2026;116:103057. PMID: 41655607. doi:10.1016/j.arr.2026.103057. PubMed 02 Wang E, Wang Y, Zhang Z, Jiang Y, Zhao C Biological properties, synthetic pathways and anti-aging mechanisms of nicotinamide mononucleotide (NMN): Research progress and challenges. Biogerontology. 2025;26(4):124. PMID: 40550930. doi:10.1007/s10522-025-10270-7. PubMed 03 Prokopidis K, Moriarty F, Bahat G, McLean J, Church DD, Patel HP The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of cachexia, sarcopenia and muscle. 2025;16(3):e13799. PMID: 40275690. doi:10.1002/jcsm.13799. PubMed 04 Nowacka A, Śniegocki M, Śniegocka M, Ziółkowska EA Nicotinamide and Pyridoxine in Muscle Aging: Nutritional Regulation of Redox, Inflammation, and Regeneration. Antioxidants (Basel, Switzerland). 2025;14(8). PMID: 40867810. doi:10.3390/antiox14080911. PubMed 05 Migaud ME, Ziegler M, Baur JA Regulation of and challenges in targeting NAD(+) metabolism. Nature reviews. Molecular cell biology. 2024;25(10):822-840. PMID: 39026037. doi:10.1038/s41580-024-00752-w. PubMed 06 Rice J, Lautrup S, Fang EF NAD(+) Boosting Strategies. Sub-cellular biochemistry. 2024;107:63-90. PMID: 39693020. doi:10.1007/978-3-031-66768-8_4. PubMed 07 Jia X, Zhang T, Yang C, Liu K, Wu L, Diao L et al. NAD(+) hydrolysis catalyzed by SelO is required for mitochondrial homeostasis. Cell. 2026;189(9):2633-2647.e24. PMID: 41806834. doi:10.1016/j.cell.2026.01.033. PubMed 08 Bao W, Liu S, Du C, Liu J, Luo X, He Y et al. Energy-replenishing, mitochondria-targeted hydrogel microspheres mitigate sarcopenia via cellular senescence amelioration. Journal of controlled release : official journal of the Controlled Release Society. 2026;391:114595. PMID: 41512967. doi:10.1016/j.jconrel.2025.114595. PubMed 09 Saka T, Hayashi R, Yoshino Y, Mitsui T, Maruyama H, Kono H et al. β-Nicotinamide mononucleotide prevents senescence and lipid accumulation in hepatic stellate cells by restoring SIRT1 function. Chemico-biological interactions. 2026;431:112012. PMID: 41796627. doi:10.1016/j.cbi.2026.112012. PubMed 10 Wen X, Chen YN, Han YC, Wang JP, Dong WH, Wang ZP et al. Nicotinamide Mononucleotide Improves High-Fat Diet-Induced Myocardial Damage of Aging Mice through the Sirt3/PINK1/Parkin Signaling Pathway. The Journal of nutrition. 2026;156(5):101435. PMID: 41763569. doi:10.1016/j.tjnut.2026.101435. PubMed 11 Yaku K, Palikhe S, Iqbal T, Hayat F, Watanabe Y, Fujisaka S et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation. Science advances. 2025;11(12):eadr1538. PMID: 40117359. doi:10.1126/sciadv.adr1538. PubMed 12 Chen M, Yuan L, Chen B, Chang H, Luo J, Zhang H et al. SLC29A1 and SLC29A2 are human nicotinamide cell membrane transporters. Nature communications. 2025;16(1):1181. PMID: 39885119. doi:10.1038/s41467-025-56402-y. PubMed 13 Zhou S, Xiong X, Hou J, Duan Q, Zheng Y, Jiang T et al. NAD+-Boosters Improve Mitochondria Quality Control In Parkinson's Disease Models Via Mitochondrial UPR. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2025;12(38):e08503. PMID: 40685704. doi:10.1002/advs.202408503. PubMed 14 Sun Z, Li J, Zheng Y, Zhang J, Bai W, Deng X et al. Small extracellular vesicles derived from mesenchymal stromal cells loaded with β-nicotinamide mononucleotide activate NAD(+)/SIRT3 signaling pathway-mediated mitochondrial autophagy to delay skin aging. Stem cell research & therapy. 2025;16(1):339. PMID: 40598314. doi:10.1186/s13287-025-04460-w. PubMed 15 Zu Y, Wu C, Li F, Yao H, Xia Y, Zhang R et al. The NAMPT enzyme employs a switch that directly senses AMP/ATP and regulates cellular responses to energy stress. Molecular cell. 2025;85(12):2271-2286.e6. PMID: 40505662. doi:10.1016/j.molcel.2025.05.022. PubMed

References are illustrative of the research literature surrounding this compound. All claims relate to in-vitro and animal models only.

[05]

FAQ

NMN (β-nicotinamide mononucleotide) is a small molecule that serves as a direct biosynthetic precursor of NAD+, the central redox cofactor of cellular metabolism. It is studied in cell and animal models for NAD+ metabolism, mitochondrial function and ageing-related endpoints. Condor Research supplies NMN strictly as a Research Use Only reference compound for in vitro and animal studies — not as a supplement, food or product for human or veterinary use.

NAD+ is the finished coenzyme that cells use directly in redox reactions and as a substrate for sirtuins and PARPs, while NMN is the immediate precursor one enzymatic step upstream, converted to NAD+ by NMNAT enzymes in the salvage pathway (Migaud et al., 2024). Research often uses precursors like NMN as a way to study NAD+ availability rather than dosing NAD+ itself (Rice et al., 2024). Both are reference compounds supplied strictly for research use only, not for human use.

Both NMN and nicotinamide riboside (NR) feed the NAD+ salvage pathway but enter at different points, and comparative work has examined how each contributes to NAD+ synthesis, including via enterohepatic circulation, and their effects on skeletal muscle (Yaku et al., 2025; Prokopidis et al., 2025). They are studied as alternative NAD+-boosting tools for different research questions. Both are supplied as research-use-only reference compounds, not for human or veterinary use.

NMN is an NAD+ precursor that feeds the salvage pathway to raise NAD+ availability, whereas 5-Amino-1MQ is studied as an NNMT inhibitor — targeting an enzyme that consumes a methyl donor and intersects NAD+/nicotinamide metabolism from the opposite direction. They approach NAD+-related biology through distinct mechanisms and serve different experimental questions. Both are supplied for research use only.

Condor Research supplies NMN exclusively as a Research Use Only reference compound for laboratory study. NMN's novel-food regulatory status in the EU is unsettled, so we deliberately apply no supplement, food or wellness framing. It is presented only as a laboratory reference material, not for ingestion or human or veterinary use.

Yes. Condor Research supplies NMN strictly as a Research Use Only reference compound to professionals and institutions, not as a medicine, supplement or product for human or veterinary use. Buyers are responsible for confirming import legality in their own country. Questions: info@condorresearch.com.

The capsule is a pre-weighed solid format that simplifies laboratory handling and inventory of a fixed quantity of NMN inside an HPMC (vegan) shell, protecting moisture-sensitive material. It is a measured solid format, not a dose, and does not imply consumption of any kind. For laboratory research use only. Not for human or veterinary use.

No. These are encapsulated — no reconstitution required. Each HPMC (vegan) capsule contains a fixed 500mg quantity of NMN in solid form for laboratory handling. The format is for research use only and is not intended for ingestion or human use.

Each bottle contains 60 HPMC (vegan) capsules, each providing 500mg of NMN at ≥99% (HPLC) purity. The capsules are independently third-party tested. The stated quantity is a pre-weighed laboratory reference format, not a human dose, and the material is for research use only.

Our NMN has CAS No. 1094-61-7, molecular formula C11H15N2O8P and a molecular weight of 334.22 g/mol. It is supplied as a white crystalline powder, soluble in water. For laboratory research use only, not for human or veterinary use.

Yes. Every NMN batch is tested by an independent third-party laboratory by HPLC for identity and purity (≥99%), and each lot ships with a lot-specific Certificate of Analysis. To request the COA for your batch, contact info@condorresearch.com. For laboratory research use only. Not for human or veterinary use.

[06]

Reviews

Leave a review
Earn 250 points for a verified review (account required).
4.7
54 verified reviews
5
78%
4
17%
3
4%
2
2%
1
0%
Apr 2026
Reproducible across batches

Third order with Condor. Batch-to-batch variation is minimal, which matters for our longitudinal work. The mono-labelled vials are easy to track.

Dr. R. Costa · Academic lab · PT Verified purchase
Mar 2026
Exactly what research needs

No marketing fluff — just characterised material with paperwork. The data sheet and CAS matched our records precisely.

J. Meijer · Biotech R&D · NL Verified purchase
Mar 2026
High purity, clear labelling

Lyophilised cake was uniform and dissolved fully. Would appreciate a digital COA portal, but the PDF on request worked fine.

Dr. A. Bianchi · University · IT Verified purchase
Feb 2026
Trustworthy supplier

Identity by MS confirmed in our facility. Communication around storage and handling was precise and professional.

K. Wójcik · Research group · PL Verified purchase

Related compounds